𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risperidone for hallucinations in levodopa-treated Parkinson's disease patients

✍ Scribed by G. Meco; A. Alessandria; V. Bonifati; P. Giustini

Book ID
118556432
Publisher
The Lancet
Year
1994
Tongue
English
Weight
315 KB
Volume
343
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cysteine elevation in levodopa-treated p
Cysteine elevation in levodopa-treated patients with Parkinson's disease
✍ Thomas MΓΌller; Wilfried Kuhn πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 305 KB πŸ‘ 1 views

## Abstract Homocysteine, cysteine, and cysteinyl‐glycine are all metabolically interrelated. Levodopa/decarboxylase inhibitor (LD/DCI) administration increases total homocysteine (tHcy) plasma levels. Objectives were to investigate associations between LD/DCI intake, concentrations of tHcy, cystei

Hyperhomocysteinemia in levodopa-treated
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia
✍ Stefano Zoccolella; Claudia dell'Aquila; Giovanni Abruzzese; Angelo Antonini; Ub πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 78 KB

## Abstract Dementia is a frequent non‐motor feature of Parkinson's disease (PD). Elevated plasma homocysteine (Hcy) levels have been associated with both cognitive impairment and dementia. Increased Hcy levels have been observed in levodopa‐treated patients with PD. The objective of our study was

Mortality of patients with parkinson's d
Mortality of patients with parkinson's disease treated with levodopa
✍ R. J. Marttila; U. K. Rinne; T. Siirtola; V. Sonninen πŸ“‚ Article πŸ“… 1977 πŸ› Springer 🌐 English βš– 372 KB

The effect of levodopa on the mortality of patients with Parkinson's disease was investigated in 349 patients treated with levodopa or levodopa combined with decarboxylase inhibitor during 1969-1975 inclusive. During the study period, 61 patients died. The expected mortality was 32.99 resulting in a